6S Pharma Solutions Private Limited

6S Pharma Solutions Private Limited - food and beverages in Gandhi Nagar,, Telangana, India. FY 2026 financials and compliance.
CIN U24304TG2018PTC123174 Incorporated 21 March 2018 ROC Hyderabad HQ Gandhi Nagar, Telangana, India
Active Private Limited Company food and beverages
Data last updated
Revenue · FY 2025
₹42.68 Lakh
▼ 91.66% YoY
EBITDA · FY 2025
*****
▲ 224.00% YoY
Net profit · FY 2025
*****
▲ 545.00% YoY
Authorised capital
₹3.3 Cr
Registered with MCA
Paid-up capital
₹3.05 Cr
Issued & subscribed
Open charges
None
Secured borrowings
Company age
8 yrs
Est. 2018
Last financials
Mar 2025
Balance sheet date

About 6S Pharma Solutions Private Limited

Data last updated: 11 March 2026

6S Pharma Solutions Private Limited is a private limited company based in Gandhi Nagar, Telangana, India. It specialises in artificial fibres, a part of the broader food and beverages sector. Incorporated on 21 March 2018, the company has been in operation for over 8 years.

Registered with ROC Hyderabad under CIN U24304TG2018PTC123174.

Capital: an authorised share capital of ₹3.3 Cr and a paid-up capital of ₹3.05 Cr. It is led by directors including Prodduturi Vikyath Reddy and Jagadeeshwar Reddy Prodduturi.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: D – 402 Sribalaji Indraprasta Apartments Old Balaji Theatre Cplx, Gandhi Nagar, Telangana, India – 500080.

As per the financials filed for FY 2025, the company reported a revenue of ₹42.68 Lakh, a growth of 0% compared to the previous year.

For more details, the company can be reached via its website 6spharma.com.

Company Details of 6S Pharma Solutions Private Limited
CIN U24304TG2018PTC123174
Registration Number 123174
Incorporation Date 21 March 2018
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Key People
Prodduturi Vikyath Reddy Director Jagadeeshwar Reddy Prodduturi Director Ashok Chandra Illapakurthy Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    **************
  • Website
    6spharma.com
  • Social Media
  • Registered Address
    D – 402 Sribalaji Indraprasta Apartments Old Balaji Theatre Cplx, Gandhi Nagar, Telangana, India – 500080
  • Industry
    Food And Beverages, Artificial Fibres, Manufacturing
Company report
6S Pharma Solutions Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full 6S Pharma Solutions Private Limited report

Financials, compliance, directors, charges, ownership and filings for 6S Pharma Solutions Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Board of Directors of 6S Pharma Solutions Private Limited

6S Pharma Solutions Private Limited is governed by 4 directors who oversee the company's operations and strategic decisions.

Current Directors
Name Designation Appointment Date Tenure Status
Prodduturi Vikyath Reddy Director 21 Mar 2018 8 Years 3 Months Current
Jagadeeshwar Reddy Prodduturi Director 09 Nov 2019 6 Years 8 Months Current
Ashok Chandra Illapakurthy Director 14 Jul 2018 7 Years 11 Months Current
Illapakurthy Amrutha Director 21 Mar 2018 8 Years 3 Months Current
View all directors

Financials of 6S Pharma Solutions Private Limited FY 2025 filings available

6S Pharma Solutions Private Limited reported revenue of ₹42.68 Lakh (up 0% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹42.68 Lakh ▲ 0%
Profit
***** ▲ 545%
EBITDA
***** ▲ 224%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF
What Is the Ownership and Shareholding Structure of 6S Pharma Solutions Private Limited?

View 6S Pharma Solutions Private Limited's control and ownership data: shareholding patterns, funding details, FII information, directors and KMP remuneration, group structure, overseas investment and related data.

Shareholding Pattern (FY 2026)
Shareholding pattern chart
  • Promoters: **.**%
  • Public: **.**%
  • Others: **.**%
Shareholding Pattern over the Year
FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Promoters**.****.****.****.****.**
Public**.****.****.****.****.**
Others**.****.****.****.****.**

Full shareholding pattern with quarterly trends.

Charges & Borrowings 6S Pharma Solutions Private Limited

6S Pharma Solutions Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at 6S Pharma Solutions Private Limited

View historical data on people associated with 6S Pharma Solutions Private Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of 6S Pharma Solutions Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of 6S Pharma Solutions Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of 6S Pharma Solutions Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for 6S Pharma Solutions Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of 6S Pharma Solutions Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by 6S Pharma Solutions Private Limited

MSME Payment Delays by 6S Pharma Solutions Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of 6S Pharma Solutions Private Limited

Subsidiaries & Group Companies of 6S Pharma Solutions Private Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of 6S Pharma Solutions Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of 6S Pharma Solutions Private Limited

MCA Filings & Documents of 6S Pharma Solutions Private Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on 6S Pharma Solutions Private Limited

Activity
30 Sep 2025
6S Pharma Solutions Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
6S Pharma Solutions Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Directors
09 Nov 2019
Jagadeeshwar Reddy Prodduturi was appointed as a Director on 09 Nov 2019 & has been associated with this company since 6 years 8 months.
Directors
14 Jul 2018
Ashok Chandra Illapakurthy was appointed as a Director on 14 Jul 2018 & has been associated with this company since 7 years 11 months.
Directors
21 Mar 2018
Prodduturi Vikyath Reddy was appointed as a Director on 21 Mar 2018 & has been associated with this company since 8 years 3 months.
Directors
21 Mar 2018
Illapakurthy Amrutha was appointed as a Director on 21 Mar 2018 & has been associated with this company since 8 years 3 months.

Frequently Asked Questions about 6S Pharma Solutions Private Limited

6S Pharma Solutions Private Limited is an active private limited company in the food and beverages sector based in Gandhi Nagar, Telangana, India. It was incorporated on 21 March 2018 (8+ years old) and is registered under CIN U24304TG2018PTC123174.

6S Pharma Solutions Private Limited reported revenue of ₹42.68 Lakh for FY 2025 (up 0.00% YoY).

The current directors of 6S Pharma Solutions Private Limited are:

The primary industry of 6S Pharma Solutions Private Limited is food and beverages. The company specifically operates in artificial fibres. The company is currently active in this sector.

6S Pharma Solutions Private Limited can be reached at the registered office: D – 402 Sribalaji Indraprasta Apartments Old Balaji Theatre Cplx, Gandhi Nagar, Telangana, India – 500080, or through the website 6spharma.com.

The authorised capital is ₹3.3 Cr, and the paid-up capital is ₹3.05 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available